Advertisement

Week 1 Sec. 2 Pain .pptx

Mar. 22, 2023
Advertisement

More Related Content

Advertisement

Week 1 Sec. 2 Pain .pptx

  1. PAIN Ms. Jehan Hadjiusman, RPh, RChT INSTRUCTOR Section 2 1 WEEK 1
  2. PAIN Pain is classified into two main categories: 1. Nociceptive pain: occurs when sensory nerves (nociceptors) identify tissue damage. Injured tissue releases substances (such as prostaglandins (PGs), substance P, histamine. which stimulate the nociceptors to send impulses to the brain that result in feeling pain. 2. Neuropathic pain: it does not result from tissue injury or damage, but from damage or malfunction of the nervous system. Such as fibromyalgia, diabetic neuropathy Background and Types of Pain
  3. Acute and Chronic Pain • Acute Pain • Begins suddenly • Never prescribe ER/LA opioids for acute pain • Chronic Pain • Persists beyond normal healing time • Cancer pain and non cancer pain N.B Pain is subjective and assessed by using pain scale where the choice of drug depends on the patient’s self-reported pain severity.
  4. NSAIDS • NSAIDs are most commonly used or mild pain but can be added to an opioid-based regimen to reduce the total opioid dose required and provide better pain relief • Acetaminophen (Tylenol) • MOA: • Reduces pain and fever (is an antipyretic) but does not provide an anti- inflammatory effect. • Inhibition of PG synthesis in the central • BW: • Severe hepatotoxicity (can require liver transplant or result in death), associated with doses> 4 grams/day or use of multiple acetaminophen- containing products.
  5. • Acetaminophen (Tylenol) • Dose: • 10-15 mg/kg Q4-6H Pediatric dose. • Conc of infant and children suspension product is 160mg/5ml • Combination products • Exist in combination with hydrocodone-oxycodone-caffeine- diphenhydramine. • Antidote • Antidote for Tylenol is NAC that restores hepatic glutathione. It is administered IV or orally using Rumac*-Matthew nomogram.
  6. • The COX-1 and 2 enzymes catalyze the conversion of arachidonic acid to PGs and thromboxane A2 (TA2). All NSAIDs decrease the formation of PGs which results in decreased inflammation. • Non-selective NSAIDs block the synthesis of both COX enzymes. COX-2 selective NSAIDs block the synthesis of COX-2 only, which decreases Gl risk because COX-1 protects the gastric mucosa • Aspirin is an irreversible COX- 1 and 2 inhibitor and is an effective antiplatelet agent that provides cardiovascular benefit.
  7. • Non-Aspirin Boxed Warnings • All prescription, non-aspirin NSAIDs require a MedGuide due to these risks. • GI Risk: NSAIDs can increase the risk of serious Gl adverse events including bleeding and ulceration. • CV Risk: NSAIDs can increase the risk of MI and stroke. Avoid use in patients with CV disease or risk factors. This warning includes all OTC non-selective NSAIDs except aspirin. • Coronary Artery Bypass Graft ( CABG) Surgery: NSAID use is contraindicated after CABG surgery. Antiplatelet therapy (commonly aspirin) is recommended after CABG surgery.
  8. • Side Effects of all NSAIDS • Used cautiously ( or avoided) in renal failure because they can decrease renal clearance • Avoid in patients with uncontrolled hypertension. Can increase blood pressure • Can cause premature closure of the ductus arteriosus. Do not use NSAIDs in the third trimester of pregnancy(> 30 weeks). • Take with food • Can cause photosensitivity Non-Aspirin NSAIDs Non-selective Increased COX-2 selectivity Ibuprofen (lower risk of GI complications) Indomethacin Celecoxib Naproxen Diclofencac Ketorolac Meloxicam and Etodolac Others Nabumetone
  9. Non-Aspirin NSAIDS 1. IBUPROFEN • OTC strength is 200 mg • Pediatric dose is 5-10mg/kg/dose Q6-8 hours • SE: dyspepsia, abdominal pain, nausea 2. INDOMETHACIN • Has high risk CNS side effects. Avoid in psych patients. • Preferred in Gout 3. NAPROXEN • Dosed BID. Preferred by les compliant patients • Used in combination medications for migraines with sumatriptan. 4. KETOROLAC • BW: max combined duration for IV/IM and PO is five days. • Warning. Not used in renal failure and liver failure 5. PIROXICAM AND SULINDAC
  10. Juanito Carlo M. Deita VI, RPh Doctor of Pharmacy, Centro Escolar University – Makati Over the Counter Drugs and Self-Care
  11. Headache • Headache – cephalgia; A painful and disabling pain in the head • Headaches include migraine, tension headache and trigeminal neuralgia such as cluster headaches. • According to GBD 2019, headache disorders are fifth cause of disability-adjusted life years (DALYs) for both adolescent and adult men and women . • 46% suffers from general headache in a year, and 64% suffered in a lifetime.
  12. Fever • Fever – pyrexia; a body temperature that is higher than normal • NOT classified as a disease but, a symptom. • Usually caused by an underlying condition (for most cases, it is caused by an infection) • COMMON clinical manifestation of COVID-19 infection. • It can also be caused by medications, external factors such as heat exhaustion or heat stroke due to too much exposure to the sun and inability to regulate temperature by sweating.
  13. What about self-care? • Management of headache and fever can be done through the use of OTC analgesics and antipyretics to relieve mild-to- moderate pain and also reduces inflammation and fever. • Analgesics are effective in treating pain of visceral origin. • According to survey of 325 parents of children, majority of them purchase OTC medicines if recommended by a physician and of the medicines were effective previously.
  14. Common OTC products for Self-Care
  15. What causes headache? • Tension-type headaches – caused by stress, anxiety, depression, emotional conflicts and other stimuli • Migraine headache • Oversleeping, missing a meal or vasoactive substances • Menstrual cycle for women • Dysfunction of trigemin0vascular system and consequent, magnesium deficiency to produce aura symptoms • Sinus headache – Infection or blockages of the paranasal sinuses • MOH Headache – Related to the overuse which causes rebound effects of analgesics.
  16. What causes fever? • Pyrogens (fever-producing substances) activates the host’s defenses, resulting in an increase hypothalamic heat regulatory set point. • Pyrogens can be exogenous or endogenous. • Prostaglandins, speficically PGE2, are produced in response to circulating pyrogens which affects the thermoregulatory set point in hypothalamus resulting to a new set point and fever occurs.
  17. Clinical Manifestation of Headache Characteristics of Tension-Type, Migraine and Sinus Headaches (Handbook of Nonprescription Drugs, 16th Edition) Tension-Type Headache Migraine Headache Sinus Headache Location Bilateral Over the top of head, extending to base of skull Usually unilateral Face, forehead or periorbital area Nature Varies from diffuse ache to tight, pressing constricting pain Throbbing May be preceded by an aura* Pressure behind eyes or face Dull, bilateral pain Worse in the morning Onset Gradual Sudden Simultaneous with sinus symptoms, including purulent nasal discharge Duration Minutes to days (If chronic – occurs at least 15 days per month for at least 6 months) Hours to 2 days Days (resolves with sinus symptoms)
  18. Clinical manifestations of Headache www.drshehadi.com/4-common-types-of-headaches-symptoms-duration/
  19. Migraine Aura migrainecanada.org/posts/the-migraine-tree/roots/migraine-categories/migraine-with-aura-an-overview Aura – Series of neurologic symptoms (shimmering or flashing areas or blind spots, visual and auditory hallucinations and usually, one- sided muscle weakness) that may last for up to 30 minutes and the throbbing headache that follows may last from hours to 2 days
  20. Exclusions for Self-Care for Headache • Chronic headache – headaches that persist for 10 days with or without treatment • Severe head pain • Last trimester of pregnancy • Younger than 8 years of age • High grade fever or signs of serious infection • Persistent nasal discharge (for sinus headache) • History of liver disease or consumption of ≥3 alcoholic drinks per day • Secondary headache – headache associated with underlying pathology such as cerebrovascular accidents • Symptoms consistent with migraine but no formal diagnosis of migraine headache
  21. Clinical Manifestation Fever • The most important sign of fever is an elevated temperature. Fever is a symptom of a larger underlying process, whether it is an infection, abnormal metabolism or drug induced. • Symptoms that accompany fever and cause a great discomfort include:  Headache  Diaphoresis  Generalized Malaise  Chills  Tachycardia  Arthralgia  Anorexia  Myalgia  Irritability
  22. Exclusion for Self-Care for Fever • Infants > 6 months with rectal temperature of ≥ 40 ºC or equivalent • Children < 6 months with rectal temperature ≥ 38 ºC • Severe symptoms of infection that are not self-limiting • Risk for hyperthermia • Impaired oxygen utilization (e.g., severe COPD, ARDS, heart failure) • Impaired immune function (e.g., cancer, HIV) • History of CNS damage (e.g., head trauma, stroke) • Children with history of febrile seizures or seizures • Fever that persists >3 days with or without treatment • Child who develops spots or rash, refuses to drink any fluids, very sleep, irritable or hard to wake up or vomiting and cannot keep down fluids
  23. Self-Care Approaches Medicines, Interventions, Practices, Dosing and Drug Selection
  24. Treatment Goals • For headache: 1. Alleviate acute pain; 2. Restore normal functioning; 3. Prevent relapse; 4. Minimize side effects; For chronic pain: reduction of frequency of headaches is an additional goal • For fever: the major goal is to alleviate the discomfort of fever by reducing the body temperature to normal range.
  25. Non Pharmacologic Interventions (Headache) • Chronic tension-type headache often respond to relaxation exercise and physical therapy that emphasizes stretching and strengthening of head and neck muscle • For migraines, interventions includes regular sleeping and eating schedule and create methods for coping stress. Moreover, nutritional strategies such as dietary restrictions of food containing triggers should be generally avoided. • Ice bags/ cold packs can applied to forehead or temporal areas to reduce pain.
  26. Non Pharmacologic Interventions (Fever) • Increase fluid intake to prevent dehydration unless fluid is contraindicated. • Sponging or baths is not routinely recommended for febrile patients with less than 40 ºC since it induces shivering leading to increase body temperature • Sponging with hydroalcoholic solutions is not recommended, especially to pediatric patients. • Wearing light apparels, removal of blankets and maintain a room temperature are proven to be beneficial.
  27. Pharmacologic Interventions • Available non-Rx for management of headache and fever includes Paracetamol/Acetaminophen, NSAIDs and Salicylates
  28. Pharmacologic Interventions Drug Mechanism of Action Acetaminophen/ Paracetamol Central inhibition of PG synthesis (including PGE2 to produce analgesia and decreases feedback between the thermoregulatory neurons and the hypothalamus, thereby reducing the hypothalamic set point during fever. NSAIDs (Ibuprofen and Naproxen) Peripheral inhibition of COX and subsequent inhibition of PG synthesis. Salicylates Irreversible inhibition of COX enzymes and subsequently, inhibits PG synthesis. (Primarily peripheral mechanism)
  29. Dosing Guidelines Drug Usual Adult Dose Usual Pediatric Dose Acetaminophen 325 – 1000 mg Q4-6 hours (MAX: 4 g) Neonate: 10 – 15 mg/kg/dose PO/PR Q6-8 hours Pediatric; 10 – 15 mg/kg/dose PO/PR Q4-6 hours (MAX: 90 mg/kg/24 hours) Ibuprofen 200 – 400 mg Q4-6 hours (MAX: 1.2 g) For infant and child ≥6 months for analgesia and antipyretic: 5-10 mg/kg/dose Q6-8hr (MAX: 40mg/kg/24 hours) Naproxen Sodium 220 mg Q8 – 12 hours (MAX: 660 mg) Child of at least >2 years: 5-7 mg/kg/dose Q8-12 hours PO (MAX: 1000 mg/ 24 hours) Child of at least 12 years: 200 mg Q8-12 PRN PO (MAX: 600 mg/ 24hr) Aspirin 650 – 1000 mg Q4 – 6 hours (MAX: 4 g) CI to children due to Reye’s Syndrome Magnesium Salicylate 650 mg Q4 hours or 1000 mg Q6 hours (MAX: 4 g)
  30. Combination Products Combination Products Caffeine + Analgesic combinations (APAP, Paracetamol) Effective treatment for variety of conditions, including tension-type and migraine headaches but may cause MOH with frequent use. NSAID/Paracetamol + Nasal decongestants Effective for sinus headache or other indications for which both analgesia and decongestion are needed. Analgesics + Antihistamine Enhanced analgesia; Effective for acute pain compared to acetaminophen alone but limited use due to sedating effects Orphenadrine/Phenyltoloxami ne + Acetaminophen
  31. Alternative Medicines For Headache
  32. Special Population Considerations (Age) • It is an important consideration in the selection of an appropriate OTC medication for both fever and headache. • Parents of children younger than 8 years old should seek the advice of their pediatrician before doing self-treatment. • Aspirin is contraindicated for children ages 15 years and below • Elderly patients are at high risk for many adverse effects of salicylates and NSAIDS. Moreover, impaired systems such as comorbidities, impaired renal function and use of other medications may contribute to the increased risk
  33. Special Population Considerations (Pregnancy) • Acetaminophen can cross the placenta, but it is considered safe during pregnancy and also, compatible with breast feeding. • NSAIDs are CI during the third trimester of pregnancy due to delay parturition, prolonged labor, increases postpartum bleeding and can cause fetal cardiovascular effects such as premature closure of ductus arteriosus. Although, both Ibuprofen and Naproxen are compatible with breastfeeding • Avoidance to aspirin is strictly advised.
  34. Patient Factors (Physiologic) • Effectiveness and safety vary among age groups. • Constantly changing physiology of pediatric patients including different pharmacokinetics and pharmacodynamics.
  35. Patient Factors (Psychological) • Cognitive ability of the patient, or with caregiver in the context of pediatrics.
  36. Patient Factors (Psychosocial) • Living environment can affect self-care. • Multiple caregivers can increase risk of miscommunication for drug administration to pediatric patients.
  37. Patient Factors (Compliance) • Ensure that the product is safe for use to increase adherence. • Intolerances to drug therapy necessitates withdrawal to the drug product, especially if the patient experiences hypersensitivity or rebound effects • Ensure that there is a need for medicines and whether the drug related need were met • Consider preferences for all ages (palatability, dosing frequency and etc.) and take note on the past medication experience.
  38. Patient Education Specific recommendations for Headache and Fever Self-Care Treatment Algorithms
  39. Aims of Patient Education • The objectives of self-treatment are to (1) relieve the symptoms of headache pain and discomfort of fever by returning the body temperature to normal, (2) prevent the symptoms of headaches and prevent complications associated with fever, (3) Prevent medication overuse, misuse or duplication of therapy.
  40. Episodic Headaches • Instruct the patient to take appropriate dose of analgesic in the early course of headache. • Patients who experiences frequent episodic headaches should be advised to keep a log of their headaches to document triggers; how frequent they experience them, the intensity and the duration of episodes and their response to treatment.
  41. Tension-Type Headaches • Non-prescription are usually effective for this condition. However, consult a medical provider before using them for chronic tension-type headache. • Keep records (how often they appear and how often they medications) and share them with their primary care physician. • Do not use products containing caffeine because of the risk of caffeine-withdrawal effects
  42. Migraine Headaches • Avoid triggers • Follow dietary restrictions • Eat regularly to avoid hunger and low sugar • Consider taking magnesium supplements • If onset of migraines are predictable (e.g., headache occurs during menstruation), take NSAIDs to prevent headache. Start taking the analgesic 2 days before you expect the headache and continue regular use during the time the headache might start. • Try to abort migraine by taking an NSAID at the onset of headache pain • If desired, use an ice bag or cold pack applied with pressure to forehead or temple to reduce the pain.
  43. Fever • Do not rely on feeling the body for fever. Take a temperature reading with an appropriate thermometer. • RECTAL measurement is preferred for children up to 6 months of age. Tympanic thermometer is not recommended in this age group due to the size and shape of the infant’s ear canal. • For 6 months to 5 years, the rectal methods is still preferred; however, the tympanic, temporal or oral method may be used if proper technique is followed • Ages 5 years and above, the oral, temporal or tympanic method is appropriate.
  44. Fever • Do not use isopropyl or ethyl alcohol for body sponging. • For all levels of fever, wear lightweight clothing, remove blankets and maintain room temperature. • Unless unadvised, drink or provide sufficient fluids to replenish body fluid loss
  45. Fever • Monitor fever and level of discomfort using the same thermometer two or three times per day. • Use OTC antipyretics/analgesics for up to 3 days only, unless you have an exclusion to self-care • Avoid alternating antipyretics because of the complexity of the dosing regimens, increased medication errors and adverse effects. • Dosing of either ibuprofen or acetaminophen in children should be based on weight. • Use appropriate measuring device
  46. Headache Treatment Algorithm
  47. Headache Treatment Algorithm
  48. Fever Treatment Algorithm
  49. Evaluation of Outcomes Fever • Primary monitoring parameters include temperature and experienced discomfort. • If symptoms did not improve during the 3-day self-care antipyretic treatment, regardless of a drop of temperature, medical consultation either by phone or appointment is needed for evaluation Headache • Follow-up will depend on the headache frequency and severity and patient factors • For all cases, the patient should seek medical attention if headaches persists longer than 10 days or become worse despite self-treatment.
  50. References • MedlinePlus [Internet]. Bethesda (MD): National Library of Medicine (US); [updated 2020 Jun 24]. Heart attack; [updated 2022 Feb 2; reviewed 2016 Dec 15; cited 2022 Mar 17]; Available from: https://medlineplus.gov/fever.html • Cann, S. A. H. (2021, January 9). Fever: Could a cardinal sign of COVID-19 infection reduce mortality? The American Journal of the Medical Sciences. Retrieved March 17, 2022, from https://www.sciencedirect.com/science/article/pii/S0002962921000045 • Islam, M. A., Kundu, S., Alam, S. S., Hossan, T., Kamal, M. A., & Hassan, R. (2021). Prevalence and characteristics of fever in adult and paediatric patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of 17515 patients. PLOS ONE, 16(4). https://doi.org/10.1371/journal.pone.0249788 • Kristoffersen, E. S., & Christofer, L. (2014). Medication-overuse headache: Epidemiology, diagnosis and treatment. Therapeutic Advances in Drug Safety, 5(2), 87-99. doi: http://dx.doi.org/10.1177/2042098614522683 • Trajanovska, M., Manias, E., Cranswick, N., & Johnston, L. (2010). Use of over-the-counter medicines for young children in Australia. Journal of Paediatrics and Child Health, 46(1-2), 5–9. https://doi.org/10.1111/j.1440-1754.2009.01609.x • Vos, T., Lim T. S., Abbafati C., et al. (2020).Global burden of 369 diseases and injuries in 204 countries and territories, 1990– 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. https://doi.org/10.1016/S0140- 6736(20)30925-9 • Trajanovska, M., Manias, E., Cranswick, N., & Johnston, L. (2010). Parental management of childhood complaints: over-the- counter medicine use and advice-seeking behaviours. Journal of clinical nursing, 19 (13-14), 2065–2075. https://doi.org/10.1111/j.1365-2702.2009.03092.x • Trajanovska, M., Manias, E., Cranswick, N., & Johnston, L. (2010). Use of over-the-counter medicines for young children in Australia. Journal of Paediatrics and Child Health, 46(1-2), 5–9. https://doi.org/10.1111/j.1440-1754.2009.01609.x • Handbook of Nonprescription Drugs: An Interactive Approach, 16th Edition • The Harriet Lane Handbook: A Manual of Pediatric House Officers, 20th Edition
Advertisement